History

Welcome to J-STAR Research

Solving Complex Chemistry Problems with Creative Solutions for 25 Years

Founded in 1996 by Dr. Andrew Thompson, formerly of Merck Research Laboratories in the Department of Process Research, J-STAR Research, Inc. is a contract chemistry organization serving as an outsourcing partner for the biopharmaceutical and biotechnology industry.

Over the past 25 years, J-Star has assembled a team of chemists, scientists and engineers committed to creatively solving complex and matrixed chemistry problems. The emphasis of this support is focused on chemistry-related problem solving centered on Active Pharmaceutical Ingredients and Intermediates in the preclinical and clinical development arena.

While high quality synthetic chemistry and process research services continue to be at J-Star’s foundation, the company has steadily added, and continues to expand, in the areas of Process Chemistry, QC, GMP and QA, Crystallization R&D, Solid Form and Polymorph Screening, Catalysis Screening + Enabling Technology, High Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation, Preformulation & Formulation R&D.

In addition to J-Star’s creative chemistry and engineering problem solving, J-Star has a track record of dependability and flexibility. This ability to adapt to changes within the dynamic preclinical and clinical R&D space, when coupled with J-Star’s unflinching focus to meet objective timelines with rigorous quality, leads to a unique value proposition for your Drug Substance or Drug Product Program.

1996

Founded and lab work started in Newark, NJ

1996

2000

Moved to new laboratory space in Plainfield, NJ

2000

2008

1st cGMP campaign

2008

2017

Acquired by Porton Pharma Solutions

2017

2017

R&D expanded to 2nd facility in Cranbury, NJ

2017

2021

Construction started on 3rd R&D facility in Cranbury, NJ

2021